Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001079973-25-000836
Filing Date
2025-05-15
Accepted
2025-05-15 18:35:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5784
  Complete submission text file 0001079973-25-000836.txt   7605
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Subject) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92271 | Film No.: 25956367
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3 ARIK EINSTEIN ST. B ENTRANCE HERZLIYA L3 4610301
Business Address 3 ARIK EINSTEIN ST. B ENTRANCE HERZLIYA L3 4610301 927(0)779800501
S.H.N. Financial Investments Ltd. (Filed by) CIK: 0001890802 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A